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Background: The cross talk between the stroma and cancer cells plays a major role in phenotypic modulation.
During peritoneal carcinomatosis ovarian cancer cells interact with mesenchymal stem cells (MSC) resulting in
increased metastatic ability. Understanding the transcriptomic changes underlying the phenotypic modulation will
allow identification of key genes to target. However in the context of personalized medicine we must consider inter
and intra tumoral heterogeneity. In this study we used a pathway-based approach to illustrate the role of cell line
background in transcriptomic modification during a cross talk with MSC.
Methods: We used two ovarian cancer cell lines as a surrogate for different ovarian cancer subtypes: OVCAR3 for
an epithelial and SKOV3 for a mesenchymal subtype. We co-cultured them with MSCs. Genome wide gene
expression was determined after cell sorting. Ingenuity pathway analysis was used to decipher the cell specific
transcriptomic changes related to different pro-metastatic traits (Adherence, migration, invasion, proliferation and
chemoresistance).
Results: We demonstrate that co-culture of ovarian cancer cells in direct cellular contact with MSCs induces broad
transcriptomic changes related to enhance metastatic ability. Genes related to cellular adhesion, invasion, migration,
proliferation and chemoresistance were enriched under these experimental conditions. Network analysis of
differentially expressed genes clearly shows a cell type specific pattern.
Conclusion: The contact with the mesenchymal niche increase metastatic initiation and expansion through cancer
cells’ transcriptome modification dependent of the cellular subtype. Personalized medicine strategy might benefit
from network analysis revealing the subtype specific nodes to target to disrupt acquired pro-metastatic profile.
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Ovarian cancer is the most deadly gynecologic cancer
with most patients dying from diffuse peritoneal disease
[1]. Defined steps involving changes of cancer cells’ phe-
notypes are implicated in the development of peritoneal* Correspondence: jat2021@qatar-med.cornell.edu
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reproduction in any medium, provided the orcarcinomatosis (reviewed in [2]). Many studies in the lit-
erature illustrate the existence of a cross talk between
cancer and stromal cells [3-5]. There are evidences that
these interactions modulate cancer cells’ phenotype and
become more invasive.
Among the different cell lines playing a role in tumor
microenvironment, mesenchymal stem cells (MSC) have
been widely studied. They are actively recruited at the
site of metastasis and their interactions with cancer cells
increase their metastatic potential. The modulation of
phenotype through cross-talk has been illustrated for
ovarian cancer. Indeed upon their interaction with mes-
enchymal cells ovarian cancer increase their migration,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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mia [5-10].
Most studies focus on specific factors in the acqui-
sition of a metastatic profile such as a cytokine or a
membrane bound factor but the translation of these find-
ings to the clinical setting has been quite disappointing
[5,10]. We can hypothesize that change of phenotype is
most probably underlined by broad transcriptomic and
epigenetic changes. Only few studies are assessing global
transcriptomic changes occurring in cancer cells upon
their interaction with MSC [3]. Zhang S et al. [3] reported
modification of the prostate cancer cells transcriptome
induced by interaction with MSCs toward a new pro-
metastatic state. Understanding the pathways impacted
by the interaction of cancer cells and their microenviron-
ment and the induced global modifications is mandatory
in order to be able to target microenvironment specific
pathways [3].
Our knowledge of ovarian cancer biology has evolved.
The broad TCGA study demonstrated the heterogeneity
of serous ovarian cancer with at least 4 different sub-
types [11]. We have illustrated the genetic (copy number
variation) and genomic (gene expression) heterogeneity
between primary and metastatic disease [12,13]. We
must therefore understand the interaction between can-
cer and stromal taking into account tumor heterogeneity
and plasticity.
We have recently shown that the interaction between
cancer cells and MSC induced a pro-metastatic pheno-
type with an increase in cell adherence, invasion, prolifera-
tion and chemoresistance [14]. The two different ovarian
cancer cell lines (OCC) used OVCAR3 and SKOV3 repre-
sent an epithelial and mesenchymal subtype respectively.
Here in this follow-up study, using Ingenuity pathway
analysis we demonstrate that genes related to cellular ad-
herence, invasion, migration, proliferation and chemore-
sistance are modified upon OCC/MSC contact in a cell
line specific manner. Our results suggest that different




We used two ovarian cancer cell (OCC) lines - SKOV3
(HTB-77) and OVCAR3 (HTB-161) - purchased from
ATCC. They were cultured in DMEM high glucose
[Hyclone, Thermo Scientific], 10% FBS [Hyclone, Thermo
Scientific], 1% Penicillin-Streptomycin-Amphotericyn B
solution [Sigma], 1X Non Essential Amino-Acid [Hyclone,
Thermo Scientific], following ATCC recommendations.
Mesenchymal cells were purchased from Stem Cells
(BM-MSC), Inc (Vancouver, CA, catalog number 70022)
maintained and expanded in culture using MesenCult®
MSC Basal Medium completed with Mesenchymal StemCell Stimulatory Supplements (Stem cell Inc, Vancouver,
CA). Their ability to differentiate in adipocytes, osteo-
blasts and chondrocytes was verified as per the supplier
instructions (data not shown). All cells were used at early
passages (less than 10). Mycoplasma screening was con-
ducted for all cell cultures.Co-cultures
We established co-cultures of eGFP-OCC (ovarian cancer
cell lines cited above an transfected by a stable GFP ex-
pressing plasmid) with BM-MSC at ratio of 1:2 for
24 hours. OCC were differentiated from BM-MSC based
on their eGFP and Ep-Cam. The different cell populations
were sorted using Fluorescence Activated Cell Sorting
(FACS). 24H was selected as the functional effects were
also assessed at this timepoint.Fluorescent activated cell sorting
Cells were harvested and blocked in PBS-5% FBS-1%
BSA-10% FcR Blocking Reagent (Myltenyi Biotec).
Single-cell suspension was analyzed and sorted on SORP
FACSAria2 (BD Biosciences). Data were processed with
FACSDiva 6.3 (BD Biosciences). Doublets were excluded
by FSC-W × FSC-H and SSC-W × SSC-H analysis, single
stained channels were used for compensation, and fluor-
ophore minus one (FMO) controls were used for gating.
eGFP fluorescence was acquired with 488 nm blue laser
and 510/50 nm emission, 50 000 events were acquired
per sample. Charts display the median of fluorescence
intensity (mfi) relative to control. During cell-sorting
purity-phase mask was applied. OCC monocultures were
processed and sorted as controls.Gene expression analysis
Upon cell sorting mRNA was isolated using Trizol re-
agent followed by purification using RNAeasy extraction
kit from Qiagen. 200 ng of total RNA were analyzed on
Affymetrix GeneChip Human Genome U133 Plus 2.0
Array. Data were analyzed using Partek software (St
Louis, MO). Class comparison between different condi-
tions (three biological replicates) was performed to
identify gene expression changes with significant ex-
pression differences and two-fold increased or decreased
expression. Principal component analysis (PCA) were per-
formed using Partek with the standard settings. Statis-
tical comparisons for microarray data were calculated
using two-tailed Students t-test. Benjamini-Hochberg
correction was applied to limit positive false discovery
rate to 5%. Statistical comparisons for categorical data
were achieved using Chi-squared test. Correlations were
performed using Pearson correlation. All other statistical
comparisons were calculated using two-tailed t-test.
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We used Ingenuity Pathway Analysis software (IPA)
(Ingenuity Systems, Redwood City, CA) for network
analysis of genes that were differentially regulated upon
co-culture. We defined global gene lists representing IPAFigure 1 Transcriptomic differences between OVCAR3 and SKOV3 and
pathway analysis network obtained when the differentially regulated genes
related to mesenchymal phenotype. Genes in green are over-expressed by
(by at least 5 folds). B. PCA analysis for the ovarian cancer cells lines alonekeywords: cell adherence, migration, invasion, proliferation,
chemoresistance, and apoptosis. We then constructed net-
works by overlaying the up and down regulated genes with
these lists. In the resulting networks genes are represented
as nodes, and biological relationships between two nodes asPCA after interaction with the mesenchymal cells. A. Ingenuity
genes between SKOV3 and OVCAR3 were overlaid on the gene list
at least 5 fold in SKOV3, genes in red are over-expressed in OVCAR3
or post-contact with the Mesenchymal cells.
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the literature, textbook, or canonical information stored in
the Ingenuity Pathways knowledge database. P-values for
enrichment of canonical pathways were generated based on
the hypergeometric distribution and calculated with the
right-tailed Fisher’s exact for 2 × 2 contingency tables as
implemented in Ingenuity.
Clinical gene expression comparison analysis
We compared our cell line expression data with publically
available data from The Cancer Genome Atlas (TCGA)
project (http://cancergenome.nih.gov/) (Additional file 1).
This data consists of 493 ovarian cancer samples from
human patients. We used normalized gene expression in-
tensities (level 3 data) precalculated by TCGA. We calcu-
lated Pearson’s correlation coefficients and associated p-values
(implemented in Matlab R2013a) between the TCGA sig-
nal intensities (493 patients) and cell line expression
changes following co-culture with MSCs for all signifi-
cantly varying cell line genes. In addition, we computed
random correlations and p-values between randomly
chosen TCGA genes and the cell line significantly varying
genes to estimate the correlations randomly expected. The
TGCA sample ids used are in the Additional file 1 text file
and the cell line expression data is in the Additional file 2
Excel file.
Results
Modification of the transcriptome of OCC upon
interaction with MSC
We compared the transcriptome of the two cell lines
used in this study OVCAR3 and SKOV3. We found that
880 genes were up or downregulated over 5 fold (FDR
0.01) illustrating that the two cell lines are quite differ-
ent. We looked at different set of genes and found thatTable 1 Most relevant networks retrieved by IPA











Molecular and cellular function
Cellular movement
Tissue developmenSKOV3 up-regulated genes related to a mesenchymal
subtype (HOX (14 fold), FAP (28 fold), TWIST (9 fold),
SNAIL (8 Fold)) when compared to OVCAR3, which dis-
played a more epithelial phenotype. PCA analysis showed
that the replicates of each experimental condition “clus-
tered” together. Gene expression pattern between all ex-
perimental conditions, were clearly distinct. Interestingly
changes in the direction of gene expression upon cell con-
tacts were distinct for both cell lines (Figure 1A and B)
(Additional file 2).
IPA global analysis of differentially expressed genes for
each cell line revealed significant enrichment of the cat-
egory “Cancer” among the super-category “Diseases and
disorders” as the most significant class. This observation
indicates that upon cell contacts cancer related genes sig-
nificantly change their expression pattern. Other enriched
classes coherent with the experimental design included
“Reproductive system disease”, “tumor morphology” and
classes related to tissue development and cellular move-
ment (Table 1). Using the genes from the “Cancer” cat-
egory we built the networks presented in Additional file 3:
Figure S1 and Additional file 4: Figure S2. While global
analysis allows understanding of relationship between
genes it is difficult to interpret when looking at particular
functions. We therefore built smaller focused networks on
specific metastatic traits described previously [14].
Gene network associated to increased OCC migration,
invasion and adherence
We have shown previously that the interaction between
MSCs and OCCs increased cell migration, invasion and
adherence [14]. Genes implicated in cellular movement,
adherence, migration and invasion were identified using
IPA (Table 2). The genes were distinct for both cell types.
In order to investigate the relationship between thections p Number of genes
3.77 10-21 167
disease 5.58 10-9 105
evelopment and function 2.85 10-5 45
1.03 10-4 49
1.9 10-12 88
disease 1.8 10-10 67
1.9 10-7 45
t 3.3 10-7 55
Table 2 Lists of differentially regulated genes modified
for each cell line as retrieved by IPA network analysis
Genes Fold
OVCAR3
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presented in Figure 2A and B.
MSC sustain ovarian cancer cells proliferation
MSC were able to sustain proliferation of OCCs for up
to 15 days in a serum free context. In order to interpret
these findings in the light of the expression data we con-
structed focused IPA networks using “proliferation” as a
keyword (Figure 3A and B).
OVCAR3 and SKOV3 presented upon co-culture con-
comitant up-regulation of different pro-proliferation genes
and down-regulation of different anti-proliferation genes.
Interestingly genes such as SPARC and COL1A1 were
regulated inversely in SKOV3 compared to OVCAR3,
again illustrating the cell-type specificity of gene expres-
sion pattern.
MSC induce chemoresistance of ovarian cancer cells
Chemotherapeutic treatment of OCC induced 65% of
cell death, while co-culture with MSC rescued OCC with
1.6 fold decrease in cell death [14]. Similarly as previ-
ously IPA network analyses suggest that OVCAR3 che-
moresistance appears to be mediated through up-regulation
of genes such as GADD45A, DDIT3, NR3C1, ATF2, and
RASGRP1 (Figure 4A). SKOV3 cell line down-regulated
the following genes implicated in apoptosis BTG2, SCD,
FASN, DDIT4 and up-regulated survival genes such as
SPARC, PDGFRA, S1PR3, KITLG, IGFBP (Figure 4B).
SKOV3 co-cultured with MSC resemble some human
tumors
To determine whether the highly significant expression
changes seen after cell lines are co-cultured with MSCs
could have some clinical relevance, we calculated the
similarity (Pearson’s correlation coefficient) between the
expression changes for each cell line and publically avail-
able human ovarian cancer expression data from 493 pa-
tients. There were 293 OVCAR3 genes and 143 SKOV3
genes for which correlations were calculated with the pa-
tient data. We find (Figure 5) that SKOV3 is positively
correlated with the tumor expression data while OVCAR3
is negatively correlated. These correlations for both cell
lines are highly significant both in terms of the associated
Figure 2 Pathways modified in OCC upon MSC contact related to adherence, migration, and invasion. A. Ingenuity Pathway Analysis
obtained from OVCAR3-eGFP following MSC contact. B. Ingenuity Pathway Analysis obtained from SKOV3-eGFP following MSC contact.
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correlations expected by random. This observation sug-
gests that SKOV3 cells after treatment with MSCs results
in gene expression changes that resemble human tumors.
In contrast, OVCAR3 gene expression changes do not re-
semble the TCGA human tumors.
Discussion
In this follow-up study we show that despite similar
phenotypic modulation different cell lines of a similar
cancer type display diverse transcriptomic modifications.
The acquisition of an increased metastatic phenotype
during the cross talk between cancer and stromal cells is
concordant with previous report in ovarian as well as
other tumor types [5,6,9,10,15]. Interestingly our ap-
proach using two different cell lines associated to a net-
work analysis illustrate that the shift of phenotype will
be dependent on the transcriptomic background. This is
quite relevant in the context of targeted therapies. Thenetwork analysis presented above allows a more detailed
interpretation of the relationship between transcriptomic
pro-metastatic changes in OCC and differences in cell
behavior upon co-culture for the different functionality
tested.
Migration, invasion and adherence
Increased adherence and invasion constitute a key step
toward peritoneal metastasis [2]. Both cell lines regu-
lated genes related to these processes; interestingly some
had opposite regulation. FN1 encoding fibronectin was
up-regulated (2-fold) in SKOV3, and down-regulated
(5.63-fold) in OVCAR3. As demonstrated by different
studies Fibronectin does not trigger similar response
in the two cell lines studied. In contrast to SKOV-3,
OVCAR-3 cells did not migrate or invade matrigel ei-
ther with or without FN [16,17]. OVCAR3 cell line
up-regulation of Twist and Zeb indicates an epithelial
to mesenchymal transition state. The expression of
Figure 3 Networks associated with increased proliferation. A. Networks involving all “proliferation” related genes in OVCAR3 upon co-culture
with MSC. B. Networks involving all “proliferation” related genes in SKOV3 upon co-culture with MSC.
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hesion to the peritoneal surfaces. The ovarian surface
epithelium (OSE) does not express E-cadherin, but
its expression appears in inclusion cysts of the ovary
and is reinforced during tumoral progression [18].
One might argue against simultaneous up-regulation
of EMT markers (TWIST, ZEB) and up-regulation of
E-cadherin and downregulation of FN1. However re-
cently a subpopulation of cells in transitory Epithelial/
Mesenchymal stage presenting increased tumorigenicity
has been described [19]. The described cell plasticityappeared to be dependent on external factors such as
co-culture with mesenchymal cells. Finally the mixed
state might represent a transient state induced by the
co-culture setting. SKOV3 cells displayed up-regulation of
MMP3 concordant with previous reports [20]. Several
pro-metastatic cytokines already described were up-
regulated such as CXCR4, and CCL2 [21,22]. Hence,
our strategy to build focused networks for specific func-
tionalities allows understanding their inter-relationship
and thereby might help designing better disrupting
strategies.
Figure 4 Pathways modified in OCC upon MSC contact related to chemoresistance. A. Ingenuity Pathway Analysis obtained from OVCAR3
following MSC contact. B. Ingenuity Pathway Analysis obtained from SKOV3 following MSC contact.
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OVCAR3 proliferation relied on NR3C1 node that has
already been described associated with liver metastasis of
gastric cancer [23]. PRKACB stabilizes elF4F expressed
at high level in different carcinomas. RhoB functions
as tumor suppressor genes and its down-regualtion
promotes cancer cell proliferation [24]. CEBPB is in-
volved in transcriptional up-regulation of SphK1 by
LPA in gastric cancers [25]. Another interesting func-
tion of CEBPB is its role in the occurrence of mesenchy-
mal phenotype in brain tumors where it is a synergistic
initiator of mesenchymal transformation with STAT3
[26]. VEGF has a role in increased proliferation and re-
sistance to anoikis of ovarian carcinomas beside its role inangiogenesis [27]. Finally SPARC modulates cell-cell and
cell-matrix interactions and demonstrates de-adhesive and
growth inhibitory properties in non-transformed cells.
Recently Said et al. showed that SPARC significantly
inhibited OVCAR3 basal and LPA-induced interleukin
IL6 production and attenuated IL-6-induced mitogenic,
chemotactic, and proinvasive properties through ERK1/2
inhibition [28,29]. Once again interestingly SPARC was
up-regulated in SKOV3. Increased SPARC is associated to
poor prognosis in pancreatic adenocarcinoma and to
lymph node metastasis in gastric cancers [30]. In melan-
oma cells SPARC promotes proliferation and survival
through akt-dependant regulation of p53 [31]. In a three
dimensional context the interaction of fibronectin and
P-value vs. Correlation 
Coefficient Scatterplots
Correlation HistogramsA B
Figure 5 Correlation of OVCAR3 and SKOV3 gene expression to patient tumors. A) Histograms of the correlation coefficients, calculated
between every patient gene expression profile and cell line gene expression profiles, show that OVCAR3 expression following MSC coculture is
negatively correlated with patient tumor expression while SKOV3 expression following MSC coculture is positively correlated. The OVCAR3 and
SKOV3 random correlation distribution as shown by the random histograms indicates that the high positive and negative correlations are not
due to chance. B) Scatterplots showing the p-value variation with the correlation coefficient indicates that the high and low correlations have
significantly low p-values. P-value scatterplots of the random correlations also show higher p-values than the sample correlations indicating
significant sample correlations.
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tion in ductal pancreatic carcinoma [32]. In a model of lung
carcinoma, inhibition of the interaction between fibronectin
and alphaV integrin resulted in reduced proliferation [33].
Chemoresistance
While many genes for both cell lines are similar to the
ones responsible for increased proliferation the centralnodes are not always the same suggesting the ability of
cancer cells to use complex transcriptomic machinery to
respond to cytotoxic stress. OVCAR3 displayed increased
GADD. The deficiency of gadd45 increases cell sensi-
tivity to UV irradiation or cisplatin [34,35]. Fibronectin
was found to be central for SKOV3 chemoresistance.
Fibronectin ligand integrin alphaVbeta1 plays a role in
multicellular aggregation and resistance to paclitaxel
Lis et al. Journal of Translational Medicine 2014, 12:59 Page 10 of 12
http://www.translational-medicine.com/content/12/1/59[36]. Moreover activation of alphaVbeta1 activates
GSK3β pro-survival signaling [37]. Finally fibronectin
mediated adhesion promotes Akt phosphorylation in
highly metastatic cancer cells A2780 and MDA-MB231,
and further induced chemoresistance against docetaxel
[38,39].
Other genes have been described in the literature in
ovarian cancer biology. However they shall not be un-
covered in our approach if they do not play a role in the
co-culture context [7,40,41]. It is hard to interpret all
the genes described in the networks in a cancer-cell au-
tonomous context. Some genes might not have the ex-
pected regulation but might play a role in the cross-talk
between OCC and MSC.
As recently illustrated in oncogenomic approaches the
role of a single genes might not be as important as path-
ways up or down-regulated. Our approach uncovered
some central nodes (such as fibronectin) and their role
will be analyzed in separate targeted functional studies.
The main question raised in this research was if broad
transcriptmic changes underlie phenotypic modulation
in cancer cells co-cultured with mesenchymal stem cells.
We have thus chosen the following experimental ap-
proach. We have co-cultured for 24 hours two different
cancer cell lines and mesenchymal cells and performed
cell sorting and transcriptomic analysis at a time-point
where we observed functional effect of the co-culture.
We then used targeted network analysis of the most sig-
nificant shifted genes and determined few networks de-
scribed above.
While we acknowledge that validation is an important
part of such studies but there are many studies where
the role of single genes or few genes were validated
without any translational relevance. Here we do not
want to demonstrate the role of any particular genes but
we want to emphasize that the interaction in vitro be-
tween stromal and cancer cells induces broad transcrip-
tomic profile that should be carefully considered when
experimental plans are designed. Interestingly showing
differential expression of genes between two routinely
used ovarian cancer cells indicate that one must be quite
careful before investigating the particular role of a single
gene.
Clinical implications
Our observation that one cell line can shift expression
to more resemble human tumors is interesting but must
be examined more closely. It is interesting because it
suggests that culturing MSCs with tumor cells can cre-
ate a better model system to study carcinogenesis since
the co-cultured tumors cells bear more resemblance to
human tumors. It is also interesting that this effect is cell
line dependent as OVCAR3 shifts farther away from hu-
man tumors after co-culture with MSC’s. However, whilethis result is interesting, it should be seen in the context
that it is difficult to compare expression data obtained at
different times and with different platforms. Neverthe-
less, this observation merits further investigation.
Other ovarian cancer cell lines need to be tested co-
cultured with different cells to obtain a broader picture
of the role of the genetic background in the interaction
with the microenvironment. Understanding the differ-
ences between ovarian serous adenocarcinoma types and
their interaction with the microenvironment would open
the path to new personalized therapeutic strategies.
Conclusion
Here we demonstrate that transcriptomic changes in-
duced by MSC co-culture were cell type specific for the
two cell lines investigated here. Many studies suggest the
role of the tumor stroma in disease progression as well
as residual disease. Understanding the interactome be-
tween the cancer and stromal cells will lead to new stroma
specific therapeutic disrupting pro-tumoral cross talk.
We have to consider tumor heterogeneity and there-
fore differential plasticity both in location and time to
tailor treatments.
Additional files
Additional file 1: Gene expression extracted from the TCGA data
sets.
Additional file 2: Transcriptomic modification of SKOV3 and
OVCAR3 after co-culture with MSCs.
Additional file 3: Figure S1. Genes network obtained from OVCAR3-eGFP
following MSC contact using all genes included in the Ingenuity Pathway
Anlaysis category “Cancer”.
Additional file 4: Figure S2. Genes network obtained from SKOV3-eGFP
following MSC contact using all genes included in the Ingenuity Pathway
Anlaysis category “Cancer”.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
Conception and design: RL, CT and ART. Acquisition of data: RL, CT, AS.
Analysis and interpretation of the data: RL, CT, NMH, AS, JM, JAM, KS, DQ and
ART. Manuscript preparation: RL, CT, NMH and ART wrote the manuscript.
Manuscript reviewing: RL, CT, DQ, NMH and ART. All authors read and
approved the final manuscript.
Acknowledgement
This publication was made possible by a grant from the Qatar National
Research Fund under its National Priorities Research Program award number
NPRP 09-1174-3-291 and NPRP 4-640-1-096. Its contents are solely the
responsibility of the authors and do not necessarily represent the official
views of the Qatar National Research Fund.
Author details
1Department of Genetic Medicine and Obstetrics and Gynecology, Stem cell
and microenvironment laboratory, Weill Cornell Medical College in Qatar
(WCMC-Q), Education City, Qatar Foundation, Qatar-Foundation PO: 24144,
Doha, Qatar. 2Department of Genetic Medicine, Weill Cornell Medical
College, New York, NY, USA. 3Institut Claudius Regaud, Toulouse F-31052,
France. 4Genomic Core, Weill Cornell Medical College in Qatar (WCMC-Q),
Lis et al. Journal of Translational Medicine 2014, 12:59 Page 11 of 12
http://www.translational-medicine.com/content/12/1/59Education city, Qatar Foundation, Doha, Qatar. 5Department of Physiology
and Biophysics, Weill Cornell Medical College, New York, NY, USA.
6Department of Gynecologic Surgery, Hospital Arnaud de Villeneuve, CHU,
Montpellier, France.
Received: 13 March 2013 Accepted: 6 February 2014
Published: 5 March 2014
References
1. Cannistra SA: Cancer of the ovary. N Engl J Med 2004, 351:2519–2529.
2. Ceelen WP, Bracke ME: Peritoneal minimal residual disease in colorectal
cancer: mechanisms, prevention, and treatment. Lancet Oncol 2009,
10:72–79.
3. Zhang S, Wang J, Bilen M, Lin S-H, Stupp S, Satcher R: Modulation of prostate
cancer cell gene expression by cell-to-cell contact with bone marrow
stromal cells or osteoblasts. Clin Exp Metastasis 2009, 26:993–1004.
4. Liu S, Ginestier C, Ou SJ, Clouthier SG, Patel SH, Monville F, Korkaya H, Heath A,
Dutcher J, Kleer CG, Jung Y, Dontu G, Taichman R, Wicha MS: Breast
cancer stem cells are regulated by mesenchymal stem cells through
cytokine networks. Cancer Res 2011, 71:614–624.
5. Lis R, Touboul C, Mirshahi P, Ali F, Mathew S, Nolan DJ, Maleki M, Abdalla SA,
Raynaud CM, Querleu D, Al-Azwani E, Malek J, Mirshahi M, Rafii A: Tumor
associated mesenchymal stem cells protects ovarian cancer cells from
hyperthermia through CXCL12. Int J Cancer 2011, 128:715–725.
6. Coffelt SB, Marini FC, Watson K, Zwezdaryk KJ, Dembinski JL, LaMarca HL,
Tomchuck SL, zu Bentrup KH, Danka ES, Henkle SL, Scandurro AB: The
pro-inflammatory peptide LL-37 promotes ovarian tumor progression
through recruitment of multipotent mesenchymal stromal cells. Proc Natl
Acad Sci 2009, 106:3806–3811.
7. Pasquet M, Golzio M, Mery E, Rafii A, Benabbou N, Mirshahi P, Hennebelle I,
Bourin P, Allal B, Teissie J, Mirshahi M, Couderc B: Hospicells (ascites-
derived stromal cells) promote tumorigenicity and angiogenesis. Int J
Cancer 2010, 126:2090–2101.
8. Martinet L, Poupot R, Mirshahi P, Rafii A, FourniÈ J-J, Mirshahi M, Poupot M:
Hospicells derived from ovarian cancer stroma inhibit T-cell immune
responses. Int J Cancer 2010, 126:2143–2152.
9. Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B, Andreeff M,
Marini F: Mesenchymal stem cell transition to tumor-associated
fibroblasts contributes to fibrovascular network expansion and tumor
progression. PLoS ONE 2009, 4:e4992.
10. Touboul C, Lis R, Al Farsi H, Raynaud CM, Warfa M, Althawadi H, Mery E,
Mirshahi M, Rafii A: Mesenchymal stem cells enhance ovarian cancer cell
infiltration through IL6 secretion in an amniochorionic membrane based
3D model. J Transl Med 2013, 11:28.
11. Cancer Genome Atlas Research N: Integrated genomic analyses of ovarian
carcinoma. Nature 2011, 474:609–615.
12. Malek JA, Martinez A, Mery E, Ferron G, Huang R, Raynaud C, Jouve E, Thiery
JP, Querleu D, Rafii A: Gene expression analysis of matched ovarian
primary tumors and peritoneal metastasis. J Transl Med 2012, 10:121.
13. Malek JA, Mery E, Mahmoud YA, Al-Azwani EK, Roger L, Huang R, Jouve E,
Lis R, Thiery JP, Querleu D, Rafii A: Copy number variation analysis of
matched ovarian primary tumors and peritoneal metastasis. PLoS One
2011, 6:e28561.
14. Lis R, Touboul C, Raynaud CM, Malek JA, Suhre K, Mirshahi M, Rafii A:
Mesenchymal cell interaction with ovarian cancer cells triggers pro-
metastatic properties. PLoS One 2012, 7:e38340.
15. Jeon ES, Moon HJ, Lee MJ, Song HY, Kim YM, Cho M, Suh D-S, Yoon M-S,
Chang CL, Jung JS, Kim JH: Cancer-derived lysophosphatidic acid stimulates
differentiation of human mesenchymal stem cells to myofibroblast-like
cells. Stem Cells 2008, 26:789–797.
16. Ahmed N, Riley C, Rice G, Quinn M: Role of integrin receptors for
fibronectin, collagen and laminin in the regulation of ovarian carcinoma
functions in response to a matrix microenvironment. Clin Exp Metastasis
2005, 22:391–402.
17. Zand L, Feng Q, Roskelley C, Leung P, Auersperg N: Differential effects of
cellular fibronectin and plasma fibronectin on ovarian cancer cell
adhesion, migration, and invasion. In Vitro Cell Dev Biol - Animal 2003,
39:178–182.
18. Sundfeldt K, Piontkewitz Y, Ivarsson K, Nilsson O, Hellberg P, Brannstrom M,
Janson PO, Enerback S, Hedin L: E-cadherin expression in human
epithelial ovarian cancer and normal ovary. Int J Cancer 1997, 74:275–280.19. Strauss R, Li ZY, Liu Y, Beyer I, Persson J, Sova P, Moller T, Pesonen S,
Hemminki A, Hamerlik P, Drescher C, Urban N, Bartek J, Lieber A:
Analysis of epithelial and mesenchymal markers in ovarian cancer
reveals phenotypic heterogeneity and plasticity. PLoS ONE 2011,
6:e16186.
20. Kenny HA, Kaur S, Coussens LM, Lengyel E: The initial steps of ovarian
cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin
and fibronectin. J Clin Invest 2008, 118:1367–1379.
21. Barbieri F, Bajetto A, Florio T: Role of chemokine network in the
development and progression of ovarian cancer: a potential novel
pharmacological target. J Oncol 2010, 2010:426956.
22. Qian B-Z, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA,
Snyder LA, Pollard JW: CCL2 recruits inflammatory monocytes to facilitate
breast-tumour metastasis. Nature 2011, 475:222–225.
23. Chang W, Ma L, Lin L, Gu L, Liu X, Cai H, Yu Y, Tan X, Zhai Y, Xu X, Zhang M,
Wu L, Zhang H, Hou J, Wang H, Cao G: Identification of novel hub genes
associated with liver metastasis of gastric cancer. Int J Cancer 2009,
125:2844–2853.
24. Couderc B, Pradines A, Rafii A, Golzio M, Deviers A, Allal C, Berg D, Penary
M, Teissie J, Favre G: In vivo restoration of RhoB expression leads to
ovarian tumor regression. Cancer Gene Ther 2008, 15:456–464.
25. Ramachandran S, Shida D, Nagahashi M, Fang X, Milstien S, Takabe K,
Spiegel S: Lysophosphatidic acid stimulates gastric cancer cell
proliferation via ERK1-dependent upregulation of sphingosine kinase 1
transcription. FEBS Lett 2010, 584:4077–4082.
26. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP,
Anne SL, Doetsch F, Colman H, Lasorella A, Aldape K, Califano A, Iavarone A:
The transcriptional network for mesenchymal transformation of brain
tumours. Nature 2010, 463:318–325.
27. Sher I, Adham SA, Petrik J, Coomber BL: Autocrine VEGF-A/KDR loop
protects epithelial ovarian carcinoma cells from anoikis. Int J Cancer 2009,
124:553–561.
28. Said NA, Elmarakby AA, Imig JD, Fulton DJ, Motamed K: SPARC
ameliorates ovarian cancer-associated inflammation. Neoplasia 2008,
10:1092–1104.
29. Tai IT, Tang MJ: SPARC in cancer biology: its role in cancer progression
and potential for therapy. Drug Resist Updat 2008, 11:231–246.
30. Miyoshi K, Sato N, Ohuchida K, Mizumoto K, Tanaka M: SPARC mRNA
expression as a prognostic marker for pancreatic adenocarcinoma
patients. Anticancer Res 2010, 30:867–871.
31. Fenouille N, Puissant A, Tichet M, Zimniak G, Abbe P, Mallavialle A, Rocchi S,
Ortonne JP, Deckert M, Ballotti R, Tartare-Deckert S: SPARC functions as an
anti-stress factor by inactivating p53 through Akt-mediated MDM2
phosphorylation to promote melanoma cell survival. Oncogene 2011,
30(49):4887–4900.
32. Schwarz RE, Awasthi N, Konduri S, Caldwell L, Cafasso D, Schwarz MA:
Antitumor effects of EMAP II against pancreatic cancer through
inhibition of fibronectin-dependent proliferation. Cancer Biol Ther 2010,
9:632–639.
33. Roman J, Ritzenthaler JD, Roser-Page S, Sun X, Han S: {alpha}5{beta}1-
integrin expression is essential for tumor progression in experimental
lung cancer. Am J Respir Cell Mol Biol 2010, 43:684–691.
34. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, Cong R,
Franzoso G: Induction of gadd45beta by NF-kappaB downregulates
pro-apoptotic JNK signalling. Nature 2001, 414:308–313.
35. Gupta M, Gupta SK, Balliet AG, Hollander MC, Fornace AJ, Hoffman B,
Liebermann DA: Hematopoietic cells from Gadd45a- and Gadd45b-
deficient mice are sensitized to genotoxic-stress-induced apoptosis.
Oncogene 2005, 24:7170–7179.
36. Dong L, Wen J, Pier E, Zhang X, Zhang B, Dong F, Ziegler N, Mysz M,
Armenta R, Cui R: Melanocyte-stimulating hormone directly enhances
UV-induced DNA repair in keratinocytes by a xeroderma pigmentosum
group a-dependent mechanism. Cancer Res 2010, 70:3547–3556.
37. De Toni-Costes F, Despeaux M, Bertrand J, Bourogaa E, Ysebaert LØ,
Payrastre B, Racaud-Sultan C: A New alpha5beta1 integrin-dependent
survival pathway through GSK3Œ ≤ activation in leukemic cells. PLoS ONE
2010, 5:e9807.
38. Xing H, Weng D, Chen G, Tao W, Zhu T, Yang X, Meng L, Wang S, Lu Y,
Ma D: Activation of fibronectin/PI-3 K/Akt2 leads to chemoresistance to
docetaxel by regulating survivin protein expression in ovarian and
breast cancer cells. Cancer Lett 2008, 261:108–119.
Lis et al. Journal of Translational Medicine 2014, 12:59 Page 12 of 12
http://www.translational-medicine.com/content/12/1/5939. Xing H, Cao Y, Weng D, Tao W, Song X, Wang W, Meng L, Xu G, Zhou J,
Wang S, Ma D: Fibronectin-mediated activation of Akt2 protects human
ovarian and breast cancer cells from docetaxel-induced apoptosis via
inhibition of the p38 pathway. Apoptosis 2008, 13:213–223.
40. Choi J-H, Park JT, Davidson B, Morin PJ, Shih I-M, Wang T-L: Jagged-1 and
Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion.
Cancer Res 2008, 68:5716–5723.
41. McLean K, Gong Y, Choi Y, Deng N, Yang K, Bai S, Cabrera L, Keller E,
McCauley L, Cho KR, Buckanovich RJ: Human ovarian carcinoma-
associated mesenchymal stem cells regulate cancer stem cells and
tumorigenesis via altered BMP production. J Clin Invest 2011,
121:3206–3219.
doi:10.1186/1479-5876-12-59
Cite this article as: Lis et al.: Mesenchymal cell interaction with ovarian
cancer cells induces a background dependent pro-metastatic
transcriptomic profile. Journal of Translational Medicine 2014 12:59.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
